Skip to Content

Join the 'Breast Cancer' group to help and get support from people like you.

Breast Cancer News

Related terms: Breast Cancer, inflammatory, Cancer, Breast, Carcinoma, Ductal, Carcinoma, Lobular, Ductal Carcinoma in Situ (DCIS), Ductal Carcinoma in Situ, DCIS

Strength Training May Prevent Side Effect of Breast Cancer Surgery

Posted 8 hours ago by Drugs.com

FRIDAY, Dec. 9, 2016 – Strength training might benefit breast cancer survivors who've undergone surgery, researchers suggest. In a small study, weightlifting appeared to help prevent swelling in the arms and chest, a common side effect of breast cancer treatment. The study included 27 breast cancer survivors who did supervised moderate-intensity strength workouts twice a week. Each woman's regimen was matched to her ability. The women were checked every two weeks. Three had reductions in swelling and the rest did not develop any swelling. Many of the women also said they were better able to perform everyday tasks, such as opening jars or lifting heavy objects. "At one time, women were told they shouldn't do upper-body activities after surgery and treatment because doctors thought it could actually cause swelling to become worse," said study author Lynn Panton. She is a professor of ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Surgical Prophylaxis, Breast Cancer - Palliative

Tamoxifen May Get Blamed for Unrelated Symptoms

Posted 9 hours ago by Drugs.com

FRIDAY, Dec. 9, 2016 – Some high-risk women who take tamoxifen to prevent breast cancer may mistake naturally occurring nausea and vomiting for side effects of the drug and stop taking it, a new study finds. Previous research has shown that taking tamoxifen can reduce the risk of breast cancer by more than 30 percent in high-risk women, and the preventive effects last more than 20 years, the study authors said. But a study of women taking tamoxifen in the United Kingdom found that one-third didn't continue the treatment for the recommended five years. Those who experienced nausea and vomiting were more likely to stop taking the drug than those without such symptoms, the findings showed. However, women who were taking an inactive placebo and had the same symptoms were equally likely to stop. That suggests that some symptoms triggered by other causes were being mistaken for side effects ... Read more

Related support groups: Breast Cancer, Tamoxifen, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Tamoxifen Hexal, Tamoxen, Genox, Nolvadex D, Tamofen, Tamosin, Emblon, Nolvadex, Soltamox, Tamone

Could a Computer Someday Guide Breast Cancer Care?

Posted 9 hours ago by Drugs.com

FRIDAY, Dec. 9, 2016 – An artificially intelligent computer system is making breast cancer treatment recommendations on a par with those of cancer doctors, a new study reports. The IBM computer system – called Watson Oncology – made treatment recommendations that jibed nine out of 10 times with those of a multidisciplinary board of doctors at a top cancer hospital in India, researchers say. In cases involving more complex cancers, however, the computer did not hit that 90 percent mark. Another version of Watson famously defeated two former winners on the game show "Jeopardy!" in 2011, winning a first-place prize of $1 million. In its oncology role, Watson digests a patient's medical history and current cancer data in under a minute. It then spends another minute reviewing all existing medical evidence regarding their particular form of cancer, said study co-author Dr. S.P. ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Breast Cancer - Male

Certain Breast Cancer Drugs Tied to Blood Vessel Damage

Posted 9 hours ago by Drugs.com

FRIDAY, Dec. 9, 2016 – Women on breast cancer drugs called aromatase inhibitors may show signs of early blood vessel damage that could lead to heart disease, a small study suggests. Researchers found that compared with healthy women their age, women on aromatase inhibitors were more likely to show signs of "endothelial dysfunction." That refers to problems in how the blood vessel lining responds to blood flow. The findings are based on just 36 women who were prescribed the drugs. And experts stressed it's too early to know what to make of the results. Still, the study adds to evidence linking aromatase inhibitors to elevated risks of high blood pressure, high cholesterol and possibly full-blown heart disease. Aromatase inhibitors include the drugs Aromasin (exemestane), Arimidex (anastrozole) and Femara (letrozole). These drugs work by lowering a woman's estrogen levels, and are often ... Read more

Related support groups: Heart Disease, Breast Cancer, Arimidex, Femara, Breast Cancer, Metastatic, Anastrozole, Letrozole, Aromasin, Exemestane, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Teslac, Testolactone, Infectious Heart Disease

New Drug Combo Shows Promise Curbing Tough-to-Treat Breast Cancer

Posted 1 day 8 hours ago by Drugs.com

THURSDAY, Dec. 8, 2016 – In women with a certain form of tough-to-treat breast cancer, treatment with a combination of two drugs appeared to keep the cancer at bay longer – from about five months to 10, a new study says. The cancer is known as "advanced hormone receptor positive, HER 2 negative" breast cancer. Women with these tumors are often given drugs called aromatase inhibitors, which work by reducing estrogen in the body and slowing the growth of the cancer. However, patients commonly develop resistance to aromatase inhibitor drugs, and they stop working. This is also known as endocrine therapy resistance. The new research may offer these patients some hope, researchers said. "Our study has shown that combining a newer medicine called everolimus [Afinitor] with a more established medicine, fulvestrant [Faslodex], has demonstrated benefit in aromatase inhibitor resistant breast ... Read more

Related support groups: Breast Cancer, Estradiol, Premarin, Ethinyl Estradiol, Estrace, Arimidex, Femara, Vagifem, Estrace Vaginal Cream, Vivelle, Breast Cancer, Metastatic, Anastrozole, Climara, Letrozole, Estring, Premarin Vaginal, Vivelle-Dot, Aromasin, Afinitor, Estradiol Patch

Breast Cancer Cells May Change When They Spread to Brain: Study

Posted 2 days 5 hours ago by Drugs.com

WEDNESDAY, Dec. 7, 2016 – When breast cancer spreads to the brain, important molecular changes may occur in the cancer, a small study found. The discovery of these changes could lead to improved diagnosis and treatment, the researchers said. About 20 percent of breast cancers are a type known as HER2-positive, which typically respond to targeted therapies. However, HER2-negative breast cancer that has spread to the brain doesn't respond to the same therapies. In this study, researchers analyzed tumors from 20 patients in the United States and Ireland. They found that primary breast cancer identified as HER2-negative switched to HER2-positive when it spread to the brain. The findings show that treatments should target not only the original breast cancer, but also brain tumors, said study author Adrian Lee, director of the Institute for Precision Medicine, part of the University of ... Read more

Related support groups: Breast Cancer, Estradiol, Premarin, Ethinyl Estradiol, Estrace, Arimidex, Femara, Vagifem, Estrace Vaginal Cream, Vivelle, Breast Cancer, Metastatic, Anastrozole, Climara, Letrozole, Estring, Premarin Vaginal, Vivelle-Dot, Aromasin, Estradiol Patch, Herceptin

Taking Breast Cancer Prevention Drug Beyond 5 Years May Not Raise Survival

Posted 2 days 10 hours ago by Drugs.com

WEDNESDAY, Dec. 7, 2016 – Many breast cancer survivors take anti-estrogen drugs for at least five years to help lessen their risk of recurrence. Now, new research suggests that taking such a drug for an even longer period might not confer any added benefit – at least in terms of survival. The study of thousands of older breast cancer survivors found that taking the aromatase inhibitor drug letrozole (Femara) for more than the recommended five years did not help them live longer. However, other benefits were noted, so the decision to extend use of drugs like these is one best made on a case-by-case basis, cancer specialists said. One oncologist who reviewed the new findings said the study has been "eagerly awaited," since many breast cancer survivors are counseled to take an aromatase inhibitor. "For now, this trial reinforces the need to listen to our patients and weigh out the risk ... Read more

Related support groups: Breast Cancer, Arimidex, Femara, Breast Cancer, Metastatic, Anastrozole, Letrozole, Aromasin, Breast Cancer - Adjuvant, Exemestane, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Breast Cancer - Male, Teslac, Testolactone

Worldwide Cancer Rates Up More Than One-Third in Past Decade: Report

Posted 5 days ago by Drugs.com

SATURDAY, Dec. 3, 2016 – Cancer cases rose 33 percent worldwide in the past 10 years, a new study shows. In 2015, there were 17.5 million diagnoses and 8.7 million deaths in the world from the disease, the researchers found. The rise in cancer cases was mainly due to population aging and growth, along with changes in age-specific cancer rates, according to the Global Burden of Disease Cancer Collaboration study. The lifetime risk of developing cancer was one in three for men and one in four for women, the researchers said. Prostate cancer was the most common type of cancer in men (1.6 million cases), and tracheal, bronchus and lung cancer was the leading cause of cancer death in men. Breast cancer was the most common cancer for women (2.4 million cases), and the leading cause of cancer death in women. The most common cancers in children were leukemia, other neoplasms, non-Hodgkin ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Melanoma, Skin Cancer, Ovarian Cancer, Cervical Cancer, Head and Neck Cancer, Testicular Cancer, Salivary Gland Cancer, Solid Tumors

After Cancer, Higher Risk of Severe Heart Attack

Posted 8 days ago by Drugs.com

THURSDAY, Dec. 1, 2016 – Cancer survivors are at increased risk for the most severe type of heart attack and require close attention to their heart health, a new study suggests. Researchers at the Mayo Clinic in Rochester, Minn., reviewed data on more than 2,300 patients who suffered this type of heart attack, called ST-elevation myocardial infarction (STEMI). One in 10 had a history of cancer, the investigators found. "We've watched cancer survivorship increase over the past two-and-a-half decades, which is wonderful. But, it has led to new challenges, such as handling of downstream illnesses and side effects to an extent never encountered before," said study senior author Dr. Joerg Herrmann. He is an interventional cardiologist at the clinic. "As cardiologists, we wanted to know if cancer and its therapies left these patients debilitated from a cardiovascular disease standpoint," he ... Read more

Related support groups: Cancer, Breast Cancer, Heart Attack, Heart Failure, Congestive Heart Failure, Colorectal Cancer, Myocardial Infarction, Left Ventricular Dysfunction, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction, Myocardial Infarction - Prophylaxis, Post MI Syndrome

Could White Wine Boost Your Melanoma Risk?

Posted 8 days ago by Drugs.com

THURSDAY, Dec. 1, 2016 – A new study raises the possibility that people who enjoy a glass of white wine every day may face a slightly elevated risk of melanoma. Total alcohol intake was associated with a 14 percent higher risk of melanoma per drink per day, researchers found. But, when they looked at the type of alcohol consumed, white wine emerged as the potential culprit. Each drink per day of white wine was associated with a 13 percent higher risk of melanoma, the researchers said. "Per drink" risk was based on 12.8 grams of alcohol – the median amount of alcohol in a beer, a glass of wine or a shot of spirits. Beer, red wine and liquor did not significantly affect melanoma risk, the study authors added. The study does not prove that white wine causes this deadly skin cancer. It merely shows an association, though one worth exploring, the researchers said. "We are just adding one ... Read more

Related support groups: Cancer, Breast Cancer, Alcohol Dependence, Colorectal Cancer, Basal Cell Carcinoma, Melanoma, Skin Cancer, Alcoholism, Hangover, Melanoma - Metastatic, Squamous Cell Carcinoma, Head and Neck Cancer, Breast Cancer, Prevention, History - Skin Cancer, Acute Alcohol Intoxication

Cancer Advances Demand Continual Funding, Specialists Say

Posted 10 days ago by Drugs.com

TUESDAY, Nov. 29, 2016 – Sufficient and sustained funding for cancer research should be a global priority, European and American cancer organizations said at the start of an international oncology conference in Germany on Tuesday. Significant progress has been made in the understanding of how cancer develops. But, consistent research funding is needed to take advantage of these advances to improve cancer survival rates, according to specialists from two of the cancer organizations sponsoring the Munich meeting. "There has never been a more exciting time in cancer research," said Dr. Denis Lacombe, director general of the European Organisation for Research and Treatment of Cancer (EORTC). "With the surge in molecular biology developments and a growing consideration for cost-benefit balance from a public health perspective, there is an increasing need to invest in cancer research and ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Bladder Cancer, Head and Neck Cancer

Never Too Old for a Mammogram?

Posted 11 days ago by Drugs.com

MONDAY, Nov. 28, 2016 – Women who think they're too old to worry about mammograms may want to reconsider the age at which their breast cancer screening years are behind them, a new study suggests. Based on an analysis of nearly 7 million mammograms over a seven-year period, "the benefit continues with increasing age up until 90," said study author Dr. Cindy Lee. She is an assistant professor in residence at the University of California, San Francisco. The question of when to stop having mammograms has been widely debated. In 2009, the U.S. Preventive Services Task Force issued new guidelines, saying there wasn't enough evidence to assess the balance of benefits and harms of screening mammography in women aged 75 and older. Lee and her colleagues looked at patient age, mammogram results, recall rates for more testing, biopsy referrals and biopsy results. The investigators also looked at ... Read more

Related support groups: Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Body Imaging

Many Women With Chronic Ills Don't Use Online Tools

Posted 11 days ago by Drugs.com

MONDAY, Nov. 28, 2016 – Chronically ill women who don't use the internet may struggle with worse health, a new study finds. "A significantly larger proportion of non-internet users reported needing help learning what to do to manage their health conditions and needing help learning how to care for their health conditions," said researcher Carolyn Mendez-Luck. She's an assistant professor in the School of Social and Behavioral Health Sciences at Oregon State University. She and her colleagues analyzed information provided by hundreds of American women aged 44 and older with at least one chronic condition. These included heart disease, cancer, stroke, diabetes, arthritis, asthma, emphysema and anxiety. More than one-third didn't use the internet. And fewer than half of those who did have access used the web to learn from others with a chronic disease, the researchers found. Also, fewer ... Read more

Related support groups: Anxiety, Anxiety and Stress, Diabetes, Type 2, Cancer, Osteoarthritis, Asthma, Heart Disease, Ischemic Stroke, Breast Cancer, Heart Attack, Asthma - Maintenance, Angina, Insulin Resistance, Colorectal Cancer, Asthma - Acute, Pre-Diabetes, Myocardial Infarction, Coronary Artery Disease (CAD), Diabetes Mellitus, Bronchiectasis

Rural Appalachia Faces Growing Cancer Crisis, Research Shows

Posted 14 days ago by Drugs.com

FRIDAY, Nov. 25, 2016 – While the rest of the United States makes major strides against cancer, a cancer crisis is taking hold in rural Appalachia. A University of Virginia (UVA) team analyzed federal government data and found that between 1969 and 2011, cancer rates fell in every U.S. region except rural Appalachia. Over the study period, rural Appalachia went from having the nation's lowest cancer death rate to the highest. Cancer death rates were nearly 15 percent higher in Virginia's rural Appalachian counties than in non-Appalachian urban areas nationwide. In rural Appalachian areas of Kentucky, cancer death rates rose 36 percent. Rural residents in every state in the Appalachian region, except Maryland, had higher cancer death rates than their urban counterparts, the study found. "Almost 40 percent more cancer mortalities [in rural Kentucky] than in the other United States. I ... Read more

Related support groups: Obesity, Cancer, Smoking, Breast Cancer

Cancer Can Devour Income of Medicare-Only Patients

Posted 16 days ago by Drugs.com

WEDNESDAY, Nov. 23, 2016 – Medical bills for older U.S. cancer patients can eat up one-quarter of their income or more if they have Medicare without supplemental insurance, a new study says. Hospitalization is a major reason why seniors with the government-funded insurance program have high out-of-pocket costs for cancer care, the researchers concluded. "The spending associated with a new cancer diagnosis gets very high quickly, even if you have insurance," said study co-author Lauren Hersch Nicholas, an assistant professor at the Bloomberg School of Public Health at Johns Hopkins University in Baltimore. "The physical disease is terrible and then you have to figure out how to deal with the economic fallout associated with paying to treat it," she said in a university news release. Nicholas and her colleagues examined data from more than 1,400 Medicare patients diagnosed with cancer ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Breast Cancer - Male, Cancer

Related Drug Support Groups

methotrexate, tamoxifen, Arimidex, fluorouracil, Femara, anastrozole, Xeloda, letrozole, Aromasin, view more... Afinitor, Herceptin, Taxol, exemestane, Taxotere, Cytoxan, cyclophosphamide, Faslodex, paclitaxel, Gemzar, capecitabine, Ibrance, gemcitabine, Adriamycin, doxorubicin, Menest, eribulin, vinblastine, docetaxel, Abraxane, Durabolin, bevacizumab, everolimus, Deca-Durabolin, Velban, Perjeta, Kadcyla, fulvestrant, Tykerb, lapatinib, nandrolone, Fareston, trastuzumab, Ixempra, Methotrexate LPF Sodium, pertuzumab, Tamoxifen Hexal, Cytadren, Trexall, Adrucil, Durabolin 50, esterified estrogens, thiotepa, Hybolin Decanoate, Halotestin, Hybolin-Improved, Tepadina, Halaven, Docefrez, Estratab, Adriamycin PFS, Androlone-D, Andryl 200, Anabolin LA, Cytoxan Lyophilized, Androxy, aminoglutethimide, Onxol, Nolvadex, fluoxymesterone, Neosar, toremifene, ixabepilone, ado-trastuzumab emtansine, palbociclib, Soltamox, paclitaxel protein-bound, Nolvadex D, Genox, Tamoxen, Tamosin, Tamofen, Emblon, Folex PFS, Adriamycin RDF, Tamone, Thioplex